In comparison to DCIS_noamp identified from HER2-positive breast cancer patients, DCIS_neg from HER2-negative breast cancer patients are also HER2 non-amplified, but they do not have the apparent potential to acquire HER2 amplification. Here, ERBB2 is linked to breast carcinoma.